EXHIBIT 23.1
------------
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
We consent to the incorporation by reference in the Registration Statement (Form
S-8) pertaining to the 1991 Stock Plan of Incyte Pharmaceuticals, Inc. and in
the related prospectus of our report dated January 24, 2000 with respect to the
consolidated financial statements and schedule of Incyte Genomics, Inc.
(formerly Incyte Pharmaceuticals, Inc.) included in its Annual Report on Form
10-K for the year ended December 31, 1999, filed with the Securities and
Exchange Commission.
ERNST & YOUNG LLP
Palo Alto, California
September 29, 2000